Skip to content
DocShifter-document-and-content-transformation-software-for-enterprises.-fast-easy-automated-scalable
  • Industries
      • Life Sciences
      • Banking & Insurance
      • Other Industries
  • Solutions

      Life Sciences

      • Submission ready PDF

      Create compliant PDFs for your regulators all around the world.

      • Automated Word Checker and Fixer

      Automatically check and fix Microsoft Word documents for styling and formatting errors.

      • Automated PDF validation

      Check and fix your PDFs to make sure they meet internal and external guidelines.

      • Automated Report Level Publishing

      Create navigation-rich, searchable PDF reports by merging documents into single or multiple PDFs. 

      • PDF/A & TIFF conversion for archiving

      Mass convert all your enterprise files to future-proof file formats such as PDF/A or TIFF.

      • Incoming e-mail converter

      Monitor e-mail inboxes and automatically convert e-mail & attachments to PDF or other formats for correspondence tracking or other purposes.

      • Audio & Video conversion

      Convert your audio and video files to the format of your choice.

      Finance and Other Regulated Industries

      • Enterprise PDF converter

      Centralize the conversion to PDF for your entire organization.

      • PDF/A & TIFF conversion for archiving

      Mass convert all your enterprise files to future-proof file formats such as PDF/A or TIFF.

      • Incoming e-mail converter

      Monitor email inboxes and automatically convert mails and attachments to PDF or other formats.

      • Automated document generation

      Generate repeatable documents by bringing templates and data together. At scale.

      • Legacy document transformation

      Convert old file formats to the latest standard to ensure accessibility and readability of your valuable content.

      • Audio & video conversion

      Convert your audio and video files to the format of your choice.

      • Document conversion services

      A team of experts to help you convert thousands of digital files to another file format. 

  • Platform
      • How does the platform work?
      The basics. Connect all your systems, convert and enrich documents.
      • Maximum scalability
      How we scale to your fluctuating demands.
      • Speed

      Discover what makes DocShifter 10x faster than comparable solutions.

      • Integrations

      See how easy it is to connect to all your enterprise systems.

      • Automated file format recognition

      Discover how DocShifter can save you time with ‘set and forget’. 

      • Supported file formats

      Discover how DocShifter helps reduce dependency on desktop tools by supporting multiple file formats.

      • OCR

      Create searchable, extractable PDFs using our built-in OCR engine.

      • Deployment

      Windows, Linux, Docker. On-premise or in the cloud. You choose.

      • High-availability

      Keep your conversion services up and running at all times.

      • Insights

      See how rendering is used within your organization. Make smarter decisions based on data.

  • Resources
      • Blog & Whitepapers

      Tips & tricks, blogs, checklists or whitepapers on document conversion, digital archiving, eCTD, regulatory submissions and many more. 

      • Product Videos

      See DocShifter in action: animation videos, product explainers, and how-to videos. 

      • Events & Webinars

      Discover our past and future webinars; and see at which events you can meet us virtually, or in person. 

      • Customer Stories

      How are our customers using DocShifter, what benefits do they see, and what do they see about working with us? 

  • Pricing
  • About Us
      • Company & Our History
      • Faces behind DocShifter
      • Partners
      • Customer Support
      • Careers
Contact Us
Blog

eCTD 4.0: Key Changes & Impact on Submission Content Preparation

Paul Ireland - VP Life Sciences

  • July 18, 2022

Related Topics

Introduction

Following our previous “What’s next after eCTD?” article, this paper aims to provide a brief update on the next major version of eCTD, version 4.0. Since 2003, eCTD has been adopted by an increasing number of Health Authorities around the world. The standard has evolved incrementally in that time. eCTD 4.0 will introduce significant updates that address many of the limitations and frustrations that both agencies and sponsors alike have identified over the last 19 years.

Who is (unfortunately) old enough to remember this?

Pile of boxes from a paper submissions to FDA in 2007.

Date: March 2007.

A submission. 500 binders for Module 5, 60 binders for Module 4, 30 binders for Module 3, 10 binders for Module 2, and 2 or 3 binders for Module 1.

In total 600 binders, each 300-350 pages totaling about 200,000 pages. Each box contains 5 binders, a pallet contains 18 boxes, so my guess is you are looking at 3 (perhaps 4) copies.

Thank you electronic submissions for taking this burden away. And thank you eCTD 4.0 for further improving the standards.

Summary

eCTD 4.0 is based on the Health Level Seven (HL7) standard called RPS (Regulated Product Submission). This standard focuses on simplifying the processing and review of regulated product information rather than the actual content itself, which will continue to develop with each iteration of the eCTD.  RPS was also designed to be used in other sectors to gain approval for medical devices, animal health and other regulated products in the future.

The primary goals of eCTD 4.0 are to:

  • Implement changes that speed up the regulatory submission process.
  • Enhance how agencies and sponsors communicate.
  • Improve global harmonization of the format.

Timelines

Despite numerous delays due to the global pandemic and other hurdles (the FDA for example planned to begin their initial pilot in 2015), a number of health authorities have completed, started or planned pilots for their implementation of eCTD 4.0. 

The most recent eCTD 4.0 Electronic Common Technical Document Implementation Dates for Health Canada, Europe, FDA, Swissmedic, Australia and Brazil.

*Please note that this image was created on 28/09/2022, and is subject to change.

The ICH published the implementation guide for eCTD 4.0 in 2018 with minor updates in June of last year. Japan- who completed their pilot last year- will be the first to begin accepting voluntary applications in the new version this year. Brazil will begin accepting applications for the very first time in eCTD directly to the version 4.0 specification from next year. By the end of 2023, currently Australia, Brazil, Canada, Japan and the US will all be accepting applications in the new version, with the EU and Switzerland starting the following year.

With the US planning to begin accepting eCTD 4.0 submissions sometime in 2023 (if the testing phase goes well) the LORENZ validation tool in use at the FDA is expected to be ready by March 2022. Initially, the use of eCTD 4.0 will not be mandatory in any region and typically only be an option for new applications. An overlap period is expected when both eCTD 4.0 and 3.2.2 submissions will run in parallel, with each country defining their own grace period of between 2 – 5 years before mandating the new version’s use.

In addition to the delays, not all aspects of eCTD 4.0 are expected to be implemented from day one. The two-way communication, which is seen as a key component of the new version, will not be implemented initially in the US, for example. Future phases will incorporate this capability and processes to continue applications initially submitted in the 3.2.2 spec in the 4.0 specification. These will be critical to the long-term success of the format. 

Key Changes in eCTD 4.0

While there will be some process changes required by the sponsors, most of the burden will be placed on the publishing and reviewer vendors to adapt their solutions to the new standards. There will be more reliance on technology by all parties to interpret the information being provided; it will no longer be possible to use a web browser to open your submissions, for example. As with any significant change to the submission standards, there will likely be a number of sponsor organisations looking at their current solution providers to ensure they still have the best technology for their needs.

To achieve the primary goals of the new specification, many updates will be implemented.

What are the key changes in the new eCTD 4.0 format? How will it impact regulatory submissions?

Implement changes that speed up the regulatory submission process.

 

  • Document re-use.

It is common for the same content to be needed multiple times throughout the lifecycle of an application. Currently, this involves submitting the same document in each sequence that it is required.

With eCTD 4.0 each document will be assigned a Universal Unique Identifier (UUID). This identifier can be referenced in future sequences, avoiding the need to resubmit the content itself.

  • Lifecycle enhancements.

To improve the management of content over longer periods of time, it will be possible to replace many documents in the application with one, or to replace one document with many. The legacy ‘append’ operation will be officially eliminated in eCTD 4.0, and it will be possible to rename documents and metadata (e.g. update the trade name).

  • Tables of Content.

The hierarchy set out in eCTD v3.2.2 will become a flat structure in eCTD 4.0. Context of Use and Keywords will be used instead to define the content’s location within any eCTD tables of content generated by the viewing tools.

  • Study Tagging Files (STFs).

Document Groups will replace the need to use Study Tagging Files, which will no longer be used in eCTD 4.0.

Enhance how agencies and sponsors communicate.

 

  • Two-way communication between sponsor and agency.

The current specification of the eCTD only allows for one-way communication from the sponsor to the agency via individual sequences. All communication from the agency to the sponsor is done separately and does not form a part of the eCTD itself.

eCTD 4.0 will also enable the agency to respond to the sponsor via a sequence, creating a full picture of the entire lifecycle of the application, including any questions or requests for information, in one single place.

  • The use of controlled vocabularies.

The increased use of agreed controlled lists is seen as an essential step in ensuring consistent communication between sponsors and agencies. These lists will be controlled by various bodies, including regional authorities, ICH and other third parties. The publishing systems will need to implement these.

Improve global harmonization of the format.

 

  • Standardization of the format with multiple Standards Organizations.

As well as the ICH, eCTD was also developed based on the HL7’s RPS (Regulated Product Submissions) project, with an aim to become an ISO standard. Along with the involvement of Health Authorities and other third parties for controlled vocabularies, the long-term vision of sponsors and agencies is to provide more content from eCTD dossier via structured data (such as that set out in the IDMP standard). This should all lead to improved harmonization of how the eCTD is implemented across different health authorities, where currently there are more differences than envisaged.

  • A new XML schema.

This has been designed to support the updated features of the new standard and be more flexible in the long-term. 

Impact on Submission Content Preparation

The PDF format will still be required for much of the content provided in the eCTD. Some minor changes to the ICH guidelines for PDF use have been defined, so it is important to ensure that the tools used for PDF generation can continue to provide compliant results. The compression method suggested for images has been adjusted for example, so sponsors should ensure they can produce PDFs to the correct new PDF specifications.

The PDF format will still be reliable in the new eCTD v4.0 format for regulatory submissions. Unstructured data will continue to provide value.

Video Recording: eCTD 4.0: What is Changing?

On September 29th we discussed eCTD 4.0 during a LinkedIn live session. We touched on topics such as the revised eCTD 4.0 implementation timeline and what changes it brings.

What can you expect in the video?

  • What is eCTD 4.0?
  • How is it different from previous versions?
  • By when do we need to be ready?
  • Why is it important?
  • What are the benefits for the sponsor organizations?
  • How does it affect the content required for a submission?
  • Are there any drawbacks?

Conclusions

As eCTD 4.0 becomes a reality, the industry as a whole will finally begin to benefit from some much-needed changes to the regulatory submission process. This in turn should lead to faster approval times and speedier access to new products for patients. The Covid-19 pandemic has only highlighted the importance of global harmonization. Sponsors should embrace these changes, and review their process as a whole, however, and not completely rely on the vendors to provide the total solution for them. It is clear that the publishing vendors in particular will need to make significant changes to their tools, but any software solution requires a well-defined business process to take full advantage of it.

With the introduction of eCTD 4.0 and the first implementations of IDMP, it is clear the next few years will be a busy time for change management within the Life Sciences industry. In the long-run, however, the benefits are clear and will be worth the effort.

Keywords: eCTD v4.0, eCTD 4.0, electronic common technical document 4.0 format, ICH, FDA, regulatory submissions, IDMP, eCTD version 4.0, eCTD 4.0 implementation, eCTD 4.0 timeline, eCTD 4.0 FDA

Content is last updated on 4 October 2022 Tuesday. 

eCTD 4.0 Key Changes & Impact on Submission Content Preparation

Introduction

Following our previous “What’s next after eCTD?” article, this paper aims to provide a brief update on the next major version of eCTD, version 4.0. Since 2003, eCTD has been adopted by an increasing number of Health Authorities around the world. The standard has evolved incrementally in that time. eCTD 4.0 will introduce significant updates that address many of the limitations and frustrations that both agencies and sponsors alike have identified over the last 19 years.

Who is (unfortunately) old enough to remember this?

Pile of boxes from a paper submissions to FDA in 2007.

Date: March 2007.

A submission. 500 binders for Module 5, 60 binders for Module 4, 30 binders for Module 3, 10 binders for Module 2, and 2 or 3 binders for Module 1.

In total 600 binders, each 300-350 pages totaling about 200,000 pages. Each box contains 5 binders, a pallet contains 18 boxes, so my guess is you are looking at 3 (perhaps 4) copies.

Thank you electronic submissions for taking this burden away. And thank you eCTD 4.0 for further improving the standards.

Summary

eCTD 4.0 is based on the Health Level Seven (HL7) standard called RPS (Regulated Product Submission). This standard focuses on simplifying the processing and review of regulated product information rather than the actual content itself, which will continue to develop with each iteration of the eCTD.  RPS was also designed to be used in other sectors to gain approval for medical devices, animal health and other regulated products in the future.

The primary goals of eCTD 4.0 are to:

  • Implement changes that speed up the regulatory submission process.
  • Enhance how agencies and sponsors communicate.
  • Improve global harmonization of the format.

Timelines

Despite numerous delays due to the global pandemic and other hurdles (the FDA for example planned to begin their initial pilot in 2015), a number of health authorities have completed, started or planned pilots for their implementation of eCTD 4.0. 

The most recent eCTD 4.0 Electronic Common Technical Document Implementation Dates for Health Canada, Europe, FDA, Swissmedic, Australia and Brazil.

*Please note that this image was created on 28/09/2022, and is subject to change.

The ICH published the implementation guide for eCTD 4.0 in 2018 with minor updates in June of last year. Japan- who completed their pilot last year- will be the first to begin accepting voluntary applications in the new version this year. Brazil will begin accepting applications for the very first time in eCTD directly to the version 4.0 specification from next year. By the end of 2023, currently Australia, Brazil, Canada, Japan and the US will all be accepting applications in the new version, with the EU and Switzerland starting the following year.

With the US planning to begin accepting eCTD 4.0 submissions sometime in 2023 (if the testing phase goes well) the LORENZ validation tool in use at the FDA is expected to be ready by March 2022. Initially, the use of eCTD 4.0 will not be mandatory in any region and typically only be an option for new applications. An overlap period is expected when both eCTD 4.0 and 3.2.2 submissions will run in parallel, with each country defining their own grace period of between 2 – 5 years before mandating the new version’s use.

In addition to the delays, not all aspects of eCTD 4.0 are expected to be implemented from day one. The two-way communication, which is seen as a key component of the new version, will not be implemented initially in the US, for example. Future phases will incorporate this capability and processes to continue applications initially submitted in the 3.2.2 spec in the 4.0 specification. These will be critical to the long-term success of the format. 

Key Changes in eCTD 4.0

While there will be some process changes required by the sponsors, most of the burden will be placed on the publishing and reviewer vendors to adapt their solutions to the new standards. There will be more reliance on technology by all parties to interpret the information being provided; it will no longer be possible to use a web browser to open your submissions, for example. As with any significant change to the submission standards, there will likely be a number of sponsor organisations looking at their current solution providers to ensure they still have the best technology for their needs.

To achieve the primary goals of the new specification, many updates will be implemented.

What are the key changes in the new eCTD 4.0 format? How will it impact regulatory submissions?

Implement changes that speed up the regulatory submission process.

 

  • Document re-use.

It is common for the same content to be needed multiple times throughout the lifecycle of an application. Currently, this involves submitting the same document in each sequence that it is required.

With eCTD 4.0 each document will be assigned a Universal Unique Identifier (UUID). This identifier can be referenced in future sequences, avoiding the need to resubmit the content itself.

  • Lifecycle enhancements.

To improve the management of content over longer periods of time, it will be possible to replace many documents in the application with one, or to replace one document with many. The legacy ‘append’ operation will be officially eliminated in eCTD 4.0, and it will be possible to rename documents and metadata (e.g. update the trade name).

  • Tables of Content.

The hierarchy set out in eCTD v3.2.2 will become a flat structure in eCTD 4.0. Context of Use and Keywords will be used instead to define the content’s location within any eCTD tables of content generated by the viewing tools.

  • Study Tagging Files (STFs).

Document Groups will replace the need to use Study Tagging Files, which will no longer be used in eCTD 4.0.

Enhance how agencies and sponsors communicate.

 

  • Two-way communication between sponsor and agency.

The current specification of the eCTD only allows for one-way communication from the sponsor to the agency via individual sequences. All communication from the agency to the sponsor is done separately and does not form a part of the eCTD itself.

eCTD 4.0 will also enable the agency to respond to the sponsor via a sequence, creating a full picture of the entire lifecycle of the application, including any questions or requests for information, in one single place.

  • The use of controlled vocabularies.

The increased use of agreed controlled lists is seen as an essential step in ensuring consistent communication between sponsors and agencies. These lists will be controlled by various bodies, including regional authorities, ICH and other third parties. The publishing systems will need to implement these.

Improve global harmonization of the format.

 

  • Standardization of the format with multiple Standards Organizations.

As well as the ICH, eCTD was also developed based on the HL7’s RPS (Regulated Product Submissions) project, with an aim to become an ISO standard. Along with the involvement of Health Authorities and other third parties for controlled vocabularies, the long-term vision of sponsors and agencies is to provide more content from eCTD dossier via structured data (such as that set out in the IDMP standard). This should all lead to improved harmonization of how the eCTD is implemented across different health authorities, where currently there are more differences than envisaged.

  • A new XML schema.

This has been designed to support the updated features of the new standard and be more flexible in the long-term. 

Impact on Submission Content Preparation

The PDF format will still be required for much of the content provided in the eCTD. Some minor changes to the ICH guidelines for PDF use have been defined, so it is important to ensure that the tools used for PDF generation can continue to provide compliant results. The compression method suggested for images has been adjusted for example, so sponsors should ensure they can produce PDFs to the correct new PDF specifications.

The PDF format will still be reliable in the new eCTD v4.0 format for regulatory submissions. Unstructured data will continue to provide value.

Video Recording: eCTD 4.0: What is Changing?

On September 29th we discussed eCTD 4.0 during a LinkedIn live session. We touched on topics such as the revised eCTD 4.0 implementation timeline and what changes it brings.

What can you expect in the video?

  • What is eCTD 4.0?
  • How is it different from previous versions?
  • By when do we need to be ready?
  • Why is it important?
  • What are the benefits for the sponsor organizations?
  • How does it affect the content required for a submission?
  • Are there any drawbacks?

Conclusions

As eCTD 4.0 becomes a reality, the industry as a whole will finally begin to benefit from some much-needed changes to the regulatory submission process. This in turn should lead to faster approval times and speedier access to new products for patients. The Covid-19 pandemic has only highlighted the importance of global harmonization. Sponsors should embrace these changes, and review their process as a whole, however, and not completely rely on the vendors to provide the total solution for them. It is clear that the publishing vendors in particular will need to make significant changes to their tools, but any software solution requires a well-defined business process to take full advantage of it.

With the introduction of eCTD 4.0 and the first implementations of IDMP, it is clear the next few years will be a busy time for change management within the Life Sciences industry. In the long-run, however, the benefits are clear and will be worth the effort.

Keywords: eCTD v4.0, eCTD 4.0, electronic common technical document 4.0 format, ICH, FDA, regulatory submissions, IDMP, eCTD version 4.0, eCTD 4.0 implementation, eCTD 4.0 timeline, eCTD 4.0 FDA

Content is last updated on 4 October 2022 Tuesday. 

Related Topics

Loading...
eCTD,Life Sciences,Pharmaceuticals,Preeya Beczek,Refusal to File (RTF),Regulatory operations,Regulatory submissions,Steve Gens

The Evolving State of Global Dossier Management

The Evolving State of Global Dossier Management

Global dossier management is a hot topic for many small...
December 5, 2022
Discover More
eCTD,Life Sciences,Regulatory operations,Regulatory submissions

Creating the right environment for structured and unstructured data to co-exist

Creating the right environment for structured and unstructured data to co-exist

There’s a lot of talk about structured information and how...
June 30, 2022
Discover More
eCTD,Life Sciences,Regulatory operations,Regulatory submissions

A Case Study in Regulatory Operations: Digital Transformation of the Workforce

A Case Study in Regulatory Operations: Digital Transformation of the Workforce

If you work in Regulatory Operations, you are probably knee-deep...
June 15, 2022
Discover More
Document transformation services - Easy and fast document conversion services by DocShifter
Document transformation services - Easy and fast document conversion services by DocShifter
Document and PDF Conversion,Enterprise content management,PDFA conversion

What You Should Know About Document Transformation Services

What You Should Know About Document Transformation Services

Mass digital document transformation is one of those things that...
June 7, 2022
Discover More
Document rendering solution for regulatory submissions
Document rendering solution for regulatory submissions
Digital archiving,Document and PDF Conversion,Document conversion,Enterprise content management,Life Sciences

What is Document Rendering, and what can it mean for your business?

What is Document Rendering, and what can it mean for your business?

Document rendering is viewed by many as simple document-to-PDF conversion....
April 5, 2022
Discover More
What is PDF-A, and how to use PDFA for your digital archive - PDF/A and TIFF conversion for digital archiving - document conversion software
What is PDF-A, and how to use PDFA for your digital archive - PDF/A and TIFF conversion for digital archiving - document conversion software
Digital archiving,Document and PDF Conversion,Enterprise content management,PDFA conversion

What is the PDF/A format, and how to use the PDF/A format for your Digital Archive

What is the PDF/A format, and how to use the PDF/A format for your Digital Archive

Many of us in business and IT set up and...
March 23, 2022
Discover More
1 2 3 Next »

Compliant, fast, automated and scalable
file format conversion for the regulated enterprise.

See what our beloved customers have to say about us:

"DocShifter is converting 36.000 documents per day, coming from all over our company (and external). We have no control over what is coming in. And still the failure rate is below 1%.

And what really sets it apart from what we were doing before, DocShifter tells us what went wrong, so we can act upon the documents that did not convert".
Operations Manager Large European Bank
"DocShifter will save us over 750 hours of manual work per year. And we expect the time savings to increase as we continue to expand our use of DocShifter.

This is significant for our clients who need the eCTD sequences to be published quickly, accurately and efficiently. "
Jennie MayDirector, Regulatory Operations - PharmaLex
"Very powerful tool for document conversion and generation. The DocShifter software goes further than our current needs, and from my point of view quite unique in the industry. Quick adaption due to user-friendly workflow creation functionalities. Possibility to create workflows in a user-friendly (non-IT) way. Possibilities for seamlessly integrations into existing solutions."
Kris V.ITS Business Partner, Clinical Development
"We are using DocShifter in conjunction with Documentum software. The rendition performance that is observed so far is more than 4000 documents per hour (on 1 single instance). The output provided is fully compliant to health authority specifications (FDA, EMA, PMDA, HC, SwissHealth, etc.) and is configurable for different countries. A true enterprise document conversion solution.”
Piyush J. Solution Manager
"We use DocShifter to prepare compliant, submission-ready PDF renditions for all regulatory content.

The product is reliable, extremely fast and produces output that is compliant with multiple Health Authorities."
Large US biotechnology companyRegulatory Information Systems Manager
"We implemented DocShifter into production and have converted over 35.000 documents. Our failure rate has dropped from over 10% to well under 0.1%. We have seen an astronomical improvement in our document conversion processes thanks to how easy DocShifter was to implement and to use. In the course of 12 months, we are going to convert more than 100.000 documents with DocShifter. Fantastic document conversion solution!”
Chris B. IT System Administrator - PeopleScout Technology
"We have documentation in different languages, but when converting everything to PDF for submissions, things got complicated really fast. Our rendition engine couldn't cope with all those fonts, and we lost a lot of time fixing problems that weren't supposed to be there in the first place. We decided to make a switch to DocShifter. Scalability during our peak times, ability to deal with multiple fonts, automation (conversion of source documents to simultaneous submission-ready PDFs for multiple health authorities) and performance. These are just some of the things that make DocShifter such a powerful rendering engine."
Jade O. Document Management Professional
"We selected DocShifter for the incredible ease-of-use, the simple configuration and implementation, the high-quality ICH compliant output, and the huge number of formats supported. Performance is excellent, and we reduced the number of rendition servers by a factor of 3. All of this, plus the company’s responsiveness made it an easy choice."
Regulatory Operations & Global Submissions SpecialistLarge pharmaceutical company
"DocShifter powers the document conversion solution in Generis’ new CARA cloud offering. “We already support many joint customers who have advanced document conversion requirements met by the integration of DocShifter with CARA. We are now happy to be able to offer this on a pre-built package with New CARA on our cloud for such customers.”
James KelleherCEO - Generis
"As we are in the middle of a paradigm shift from analogue to digital in Japan, I have been looking for the right solution to support this for many years. In DocShifter we have found a company with solutions that have been selected by organizations of all sizes because of their responsiveness, cost-effectiveness, class-leading performance and unique capabilities that rise above the competition.”
Kosuke OmodaPresident - eSA Japan
"One of the things we love about DocShifter is the graphic interface to configure file transformation flows. The user interface is very simple to use and rare to find within other similar document conversion products. Wide selection of connectors to different solutions (EIM & DMS systems) make DocShifter a great choice for our company as well. We also are very happy with the customer support we receive: extremely friendly and prompt.”
Nikita L.Information Management Consultant
"With DocShifter, we are seeing better performance with even less resources, compared to our previous solution. The deployment is very easy, and the utilization of hardware/software resources are extremely efficient. Thanks to DocShifter's architecture and not needing Office applications, we were able to save a lot of money and resources by the switch.”
Istvan V.Solution Architect
Previous
Next

15 years of experience in automating, simplifying and speeding up document conversion.
For all regulated industries. 

 

 

Rated 5 stars on Gartner’s Capterra platform.

DocShifter document conversion solution is rated 5 starts by our customers on Gartner's Capterra platform.

Contact us

  • hello@docshifter.com
  • +32 (0)9 242 87 39
  • Address
    Eedverbondkaai 242/003
    B-9000 Gent
    Belgium
  • VAT (BTW) Number
    BE0544.961.044

Schedule an intro call

© 2022 DocShifter. All rights reserved.
Privacy policy
Disclaimer
Security

We are using cookies on our website. Cookies that are used, can be viewed in the settings section.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.